Tuesday, May 17, 2022
News

Curadev Pharma joins NBEC to boost Indian Biotech Startups: Sponsors cash prize and potential investment opportunity to selected winners

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Business | January 11, 2022 11:51:07 AM IST
Noida (Uttar Pradesh) [India], January 11 (ANI/PRNewswire): As part of our 'Recognizing Excellence' initiative, Curadev took part in the National Bio Entrepreneurship Competition (NBEC) that was launched on 16th August 2021.

Senior members of Curadev were members of the jury that assessed 320 short-listed applications and ideas that came from students with business concepts and established startups.

Curadev sponsored a cash prize of Rs 3 lakhs to an entrepreneur in the student category for the design of a combined ventilator and aerosol delivery system for patients with respiratory distress. Curadev also offered one existing startup an opportunity to present an investment proposal for $50,000 to the Curadev Board.

NBEC is organized every year by Centre for Cellular and Molecular Platforms, a Department of Biotechnology, Government of India supported organization. The competition aims to attract, identify and nurture game-changing deep science ideas with business potential. NBEC 2021 declared 17 Startups and 5 student teams as winners who closely contested over a period of four months that attracted 2500 applications from across India.

The winners this year addressed challenges in medical devices, antimicrobial resistance, drug discovery, diagnostics, agri-biotechnology, water & sanitation, industrial biotechnology, maternal & child health, and clean technology.

We are a small molecule drug discovery biotech with an exciting portfolio of research programs that have yielded patent protected drug candidates. Founded in 2010, Curadev has created a premier translational research organization known for prescient target selection and high quality, data-driven program execution. Our programs seek to ameliorate disease by translating cutting edge discoveries into new medicines. We have swiftly established our credentials by successfully creating and out-licensing our small molecule patents to major pharmaceutical companies.

To know more about Curadev, visit our website www.curadev.in.

Connect with us:

Business enquiries : business@curadev.in

Career opportunities : hr@curadev.in

All other enquiries : interact@curadev.in

CONTACT: Manish Tandon,Co-founder & CFO, Curadev Pharma, interact@curadev.in, Phone: +91-120-4081818

This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
Cyril Amarchand Mangaldas advises Adani ...
'Selective secularism is dangerous for t...
LIC witnesses tepid listing, market cap ...
The Highbrooks Cafe: The coffee brand th...
Dr Ashwath Narayan to deliver keynote at...
QNET India introduces the elixir of heal...
More...
 
INDIA WORLD ASIA
CBI inspector fights at party, sent back...
KTR takes a jibe at PM over 'Acche Din'...
Rainfall, light to heavy, to continue ov...
Fault lines widening amongst Indian Musl...
Rajasthan's Ramgarh Vishdhari Sanctuary ...
Telangana Cong to urge Rahul Gandhi to l...
More...    
 
 Top Stories
Angel Di Maria set to leave PSG for... 
Aditya Birla Group's Hindalco Ind L... 
Pakistan: PTI government local repr... 
Delhi HC dismisses plea moved by fo... 
Manakamna Group launches Home Squar... 
Hangzhou 2022 Asian Para Games post... 
Sri Lanka: Parliament rejects oppos... 
Adoption of Voice Technology crucia...